Background The study aimed to describe the clinical course, outcomes, and prognostic factors of chronic obstructive pulmonary disease (COPD) patients with acute hypercapnic respiratory failure.
Methods This retrospective study involved patients with acute hypercapnic respiratory failure due to COPD of any cause admitted to the intensive care unit (ICU) for non-invasive or invasive mechanical ventilation (IMV) support between December 2015 and February 2020.
Results One hundred patients were evaluated. The main causes of acute hypercapnic respiratory failure were bronchitis, pneumonia, and heart failure. The patients’ mean Acute Physiology and Chronic Health Evaluation (APACHE) II score was 23.0±7.2, and their IMV rate was 43%. ICU, in-hospital, and 90-day mortality rates were 21%, 29%, and 39%, respectively. Non-survivors had more pneumonia, shock within the first 24 hours of admission, IMV, vasopressor use, and renal replacement therapy, along with higher APACHE II scores, lower admission albumin levels and PaO2/ FiO2 ratios, and longer ICU and hospital stays than survivors. Logistic regression analysis identified APACHE II score (odds ratio [OR], 1.157; 95% confidence interval [CI], 1.017–1.317; P=0.026), admission PaO2/FiO2 ratio (OR, 0.989; 95% CI, 0.978–0.999; P=0.046), and vasopressor use (OR, 8.827; 95% CI, 1.650–47.215; P=0.011) as predictors of ICU mortality. APACHE II score (OR, 1.099; 95% CI, 1.021–1.182; P=0.011) and admission albumin level (OR, 0.169; 95% CI, 0.056–0.514; P=0.002) emerged as predictors of 90-day mortality.
Conclusions APACHE II scores, the PaO2/FiO2 ratio, vasopressor use, and albumin levels are significant short-term mortality predictors in severely ill COPD patients with acute hypercapnic respiratory failure.
Citations
Citations to this article as recorded by
Acute hYpErcapnic respiratory failure in The ICU: A multicenter prospective observational study - The YETI study Claire Dupuis, Toufik Kamel, Christophe Beyls, Charlène Le Moal, Pierre Garcon, Suzanne Goursaud, Laetitia Bodet-Contentin, Alexis Ferré, Max Guillot, Alexandre Gachet, Thibaut Noel, Aude Garin, Laurent Argaud, Konstantinoss Bachoumas, Romain Persichini, Annals of Intensive Care.2026; 16: 100016. CrossRef
Breaking new ground: machine learning enhances survival forecasts in hypercapnic respiratory failure Zhongxiang Liu, Bingqing Zuo, Jianyang Lin, Zhixiao Sun, Hang Hu, Yuan Yin, Shuanying Yang Frontiers in Medicine.2025;[Epub] CrossRef
Efficacy and safety of medroxyprogesterone acetate on noninvasive ventilation -treated exacerbated COPD patients: a double-blind randomized clinical trial Mohsen Gholinataj Jelodar, Mohammadreza Malek-Ahmadi, Adeleh Sahebnasagh, Farhad Mohammadi, Fatemeh Saghafi BMC Pulmonary Medicine.2025;[Epub] CrossRef
From acute phase to rehabilitation: bridging the gap and improving the pathway for Chronic Obstructive Pulmonary Diseases patients (Summary of a Pulmonologists’ Audit - September-December 2024) Michele Vitacca, Massimiliano Beccaria, Luca Bianchi, Paolo Ceruti, Maurizio Marvisi, Monia Betti, Michela Bezzi, Francesco Tursi Multidisciplinary Respiratory Medicine.2025;[Epub] CrossRef
Construction and validation of a nomogram prediction model for death risk in patients with chronic obstructive pulmonary disease complicated by hypercapnic respiratory failure in the intensive care unit Ye Zhang, Hao Chen, Shiyu Hu, Chengshui Chen, Wenyu Chen Respiratory Medicine.2025; 245: 108188. CrossRef
Letter to Editor in Response to Article “Estimation of Predictors of Mortality in Patients with Acute Respiratory Failure Secondary to Chronic Obstructive Pulmonary Disease Admitted in Tertiary Care Center” J Assoc Physicians India 2025;73(2):35–38 Madhusudan Barthwal, Sachinkumar S Dole Journal of The Association of Physicians of India.2025; 73(8): 104. CrossRef
Role of Arterial Blood Gas in Risk Stratification of Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Emergency Department: A Systematic Review Iman Fatima, Jaipal Dass, Zakia Rauf Aslam, Muhammad Miraj Khan, Hassan Imtiaz, Havil Stephen Alexander Bakka, Muhammad Aqib Mazhar, Saif Abdulsattar, Areeba Zahid, Inam Rafiq Cureus.2025;[Epub] CrossRef
RESPIRATORY SUPPORT FOR CHRONIC HYPERCAPNIC RESPIRATORY FAILURE IN THE OUTPATIENT SETTINGS. LITERATURE REVIEW.
A.S. Serikova, I.Y. Mukatova, S.A. Baidurin, Zh.M. Urazalina Наука и здравоохранение.2025; (4(27)): 183. CrossRef
Antibiotics in COPD exacerbations requiring mechanical ventilation: a dogma to be re-evaluated Sebastian Osorio-Rico, Daniel Perez-Marin, John Cardeño-Sanchez Internal and Emergency Medicine.2024; 19(5): 1505. CrossRef
Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases Qi Li, Qinghong Liao, Shulei Qi, He Huang, Siyu He, Weiping Lyu, Jinxin Liang, Huan Qin, Zimeng Cheng, Fan Yu, Xue Dong, Ziming Wang, Lingfei Han, Yantao Han European Journal of Medicinal Chemistry.2024; 271: 116386. CrossRef
Development and Validation of an In-Hospital Mortality Prediction Model for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Wenjie Sun, Yeshan Li, Shuxin Tan International Journal of Chronic Obstructive Pulmonary Disease.2024; Volume 19: 1303. CrossRef
Value of diaphragmatic ultrasound parameters in assessing weaning outcomes and survival in ventilator-dependent intensive care unit patients Liuhua Pan American Journal of Translational Research.2024; 16(12): 7830. CrossRef
COPD Exacerbation: Why It Is Important to Avoid ICU Admission Irene Prediletto, Gilda Giancotti, Stefano Nava Journal of Clinical Medicine.2023; 12(10): 3369. CrossRef